Moore v. Commissioner of Social Security Administration

CourtDistrict Court, N.D. Ohio
DecidedApril 9, 2024
Docket1:23-cv-01080
StatusUnknown

This text of Moore v. Commissioner of Social Security Administration (Moore v. Commissioner of Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Moore v. Commissioner of Social Security Administration, (N.D. Ohio 2024).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

JESSICA MOORE, CASE NO. 1:23-CV-01080-DAC

Plaintiff, MAGISTRATE JUDGE DARRELL A. CLAY

vs. MEMORANDUM OPINION AND ORDER

COMMISSIONER OF SOCIAL SECURITY ADMINISTRATION,

Defendant.

INTRODUCTION Plaintiff Jessica Moore challenges the Commissioner of Social Security’s decision denying disability insurance benefits (DIB). (ECF #1). The District Court has jurisdiction under 42 U.S.C. §§ 1383(c) and 405(g). On May 30, 2023, pursuant to Local Civil Rule 72.2, this matter was referred to me to prepare a Report and Recommendation. (Non-document entry dated May 30, 2023). Following review, and for the reasons stated below, I AFFIRM the Commissioner’s decision. PROCEDURAL BACKGROUND Ms. Moore filed for DIB on July 26, 2021, alleging a disability onset date of June 1, 2020. (Tr. 147). The claim was denied initially and on reconsideration. (Tr. 54-59, 61-67). She then requested a hearing before an Administrative Law Judge. (Tr. 89-90). Ms. Moore (represented by counsel) and a vocational expert (VE) testified before the ALJ on July 18, 2022. (Tr. 34-53). On September 1, 2022, the ALJ issued a written decision finding Ms. Moore not disabled. (Tr. 14-29). The Appeals Council denied Ms. Moore’s request for review, making the hearing decision the final decision of the Commissioner. (Tr. 1-3; see 20 C.F.R. §§ 404.955, 404.981). Ms. Moore timely

filed this action on May 30, 2023. (ECF #1). FACTUAL BACKGROUND I. Personal and Vocational Evidence Ms. Moore was 25 years old on the alleged onset date, making her a younger individual age 18-49 according to the regulations. (Tr. 27). She completed high school and a four-year degree. (Tr. 27, 37). In the past, she worked as an informal waitress, a fast-food worker, a customer service representative, and as an English as a Second Language (ESL) teacher. (Tr. 27).

II. Relevant Medical Evidence On January 15, 2020, Ms. Moore reported to her primary care physician, Gwen Haas, M.D., , that when she is cold, she has redness, pain, and stiffness in her joints (hands, fingers, hips, knees, feet, and toes), is lethargic, has extreme thirst, and experiences unexplained shortness of breath. (Tr. 288). Dr. Hass observed a multitude of symptoms, including cold intolerance, polyarthralgias, lethargy, extreme thirst, and shortness of breath with some air hunger but no

wheezing or cough. (Id.). Dr. Hass assessed Ms. Moore with polyarthralgia, cold intolerance, thirst, shortness of breath, and possible Raynaud’s phenomenon without gangrene and recommended she schedule her overdue routine medical in the next week or two. (Tr. 289-90). The same day, Ms. Moore presented to the emergency department with the same complaints, as well as a complaint of abnormal labs drawn earlier that day at her doctor’s office. (Tr. 237, 241). Her neurological examination revealed no obvious deficits; she exhibited normal sensation and strength bilaterally and could ambulate. (Tr. 247). She was diagnosed with dyspnea and joint pain and discharged with instruction to follow up with her primary care physician as an outpatient. (Tr. 250).

Ms. Moore followed up with Dr. Haas on January 21, 2020, who reviewed an elevated D- dimer level but the CT angiogram from the emergency department was negative for pulmonary embolism. (Tr. 284). She continued to complain of dyspnea, temperature intolerance, and fatigue. (Id.). After ruling out acute issues such as pulmonary embolism, Dr. Haas referred Ms. Moore to a rheumatologist. (Tr. 286). Ms. Moore treated with rheumatologist David Mandel, M.D., on July 1, 2020, complaining of using ibuprofen with some regularity due to pain, stiffness, and soreness in her wrists and

hands. (Tr. 336). Upon entering the office, her temperature was taken and she had no fever; she also had no extra rheumatic symptoms such as psoriasis, iritis, or colitis. (Id.). On examination, she had “very subtle slight synovial thickening over the top of both wrists, particularly the left wrist” but no palpable synovitis of the proximal interphalangeal (PIP) or metacarpophalangeal (MCP) joints, nor signs of flexor tenosynovitis in her hands. (Id.). Her pinch and grip were good, she had no effusion of the knees or ankles, and sensation in her hands was intact. (Id.). Dr. Mandel

assessed her with early onset polyarthritis, inflammatory-type, and arthralgias. (Tr. 337). He sent her for bloodwork including a Vectra DA profile. (Id.). The Vectra score was high at 53, indicating an increased risk for radiographic progression; Dr. Mandel recommended adjusting the treatment regimen to reduce inflammation. (Tr. 346). On July 15, 2020, Ms. Moore followed up with Dr. Mandel to discuss lab results. (Tr. 332). He diagnosed her with seronegative inflammatory arthritis, early onset polyarthritis and arthralgias with multiple joint involvement and marked elevation of acute phase reactant studies. (Id.). On examination, Dr. Mandel observed Ms. Moore had tenderness and pain to palpation over both shoulders, “some tenderness” of the left subdeltoid bursa and both wrists, and “slightly decreased”

grip and pinch. (Tr. 332-33). Dr. Mandel started Ms. Moore on 300 mg daily Plaquenil. (Tr. 333). On September 23, 2020, Ms. Moore met with Dr. Mandel for follow up. (Tr. 329). He noted she had started Plaquenil earlier in the summer and was “feeling remarkably better” with less morning pain, stiffness, swelling, and fatigue. (Id.). She was continuing to work virtually as an ESL teacher and was engaging in some structured strengthening exercises. (Id.). On examination, Dr. Mandel observed “definite reduced swelling over her wrists and knuckles,” negative prayer and

Tinel signs, no tenderness of the hips or knees, no effusions, and good pinch and grip. (Id.). He noted she was on remittive therapy, recommended an annual eye exam while on Plaquenil, and directed her to follow up in four to five months. (Tr. 329-30). At follow up on December 15, 2020, Ms. Moore reported struggling with constipation the past two to three months, but no melena or diarrhea; Dr. Mandel decided to discontinue Plaquenil for two weeks to assess its effect on Ms. Moore’s constipation and recommended she follow up with Dr. Haas and gastroenterology. (Tr. 326-27). Ms. Moore believed the Plaquenil was

“quite helpful,” and Dr. Mandel noted reduction in acute phase reactant studies. (Tr. 326). On examination, Ms. Moore had minimal swelling and pain over her wrists, flexion and extension of the wrists was slightly limited, no effusion in the knees or ankles, some pain and tenderness over the right hip and right trochanteric bursa, but she exhibited negative Tinel and Phalen signs. (Id.). On February 24, 2021, Ms. Moore met with Dr. Mandel, who noted she had a gastrointestinal workup with no signs of inflammatory bowel disease; she had made some dietary changes and had not had any abdominal cramping or melena. (Tr. 321). She was no longer working her teaching job. (Id.). She had stiffness and soreness in her hands and wrists, and at times had difficulty taking lids off jars and difficulty squeezing and holding materials. (Id.). Her RAPID-3

and MD global scores showed a moderate amount of pain. (Id.). She had pain to palpation over both hands, diminished strength, painful Tinel sign on the left, and slight tenderness over her hips. (Tr. 321, 323). Laboratory findings supported an underlying inflammatory process. (Tr. 323). She had been using several Aleve and Tylenol each day because of pain; Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sullivan v. Zebley
493 U.S. 521 (Supreme Court, 1990)
Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Robert M. Wilson v. Commissioner of Social Security
378 F.3d 541 (Sixth Circuit, 2004)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Sheeks v. Commissioner of Social Security Administration
544 F. App'x 639 (Sixth Circuit, 2013)
Kimberly Smith-Johnson v. Comm'r of Social Security
579 F. App'x 426 (Sixth Circuit, 2014)
Christopher Forrest v. Comm'r of Social Security
591 F. App'x 359 (Sixth Circuit, 2014)
Carter Turner v. Commissioner of Social Security
381 F. App'x 488 (Sixth Circuit, 2010)
Francis v. Commissioner Social Security Administration
414 F. App'x 802 (Sixth Circuit, 2011)
Jacqueline Brooks v. Commissioner of Social Securit
531 F. App'x 636 (Sixth Circuit, 2013)
McPherson v. Kelsey
125 F.3d 989 (Sixth Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Moore v. Commissioner of Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/moore-v-commissioner-of-social-security-administration-ohnd-2024.